“…Additionally, it is reported to activate the 5′-AMP-activated protein kinase in different tissues, chiefly in liver leading to enhanced insulin sensitivity. 27,28 Role of metformin in reducing blood pressure levels in patients with T2DM is variable; however, a potential of metformin in lowering blood pressure in patients with impaired glucose tolerance or impaired fasting glucose is an established evidence. 4,29,30 In addition, metformin therapy is also linked to improvements in lipoprotein metabolism, as well as in cardiovascular mechanisms such as endothelial dysfunction, oxidative stress, and fat redistribution.…”